idiopathic pancreatitis inflammation of the pancreas with an unknown origin
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: At least 18 years oldEligible for early cholecystectomyFull required diagnostic work-up of patient has been performed, including EUSFirst, second or third episode of IAP, in which at least one episode characterized by a negative EUS result has been reportedInformed consent for participation was obtained
Exclusion criteria
Exclusion criteria: 1. Patients with more than 3 episodes of idiopathic acute pancreatitis 2. Diagnosis of chronic pancreatitis 3. Patients with a pancreatic malignancy 4. Patients who have received a laparoscopic cholecystectomy prior to PICUS-2 5. Patients in whom a known etiology is found during diagnostic work-up 6. Patients in whom complete diagnostic work-up by EUS is not possible (eg. Roux-en-y bypass)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure for this trial is a confirmed recurrent acute pancreatitis (irrespective of the aetiology of recurrent pancreatitis) within one year from the date of randomization | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome measures for this trial are - Readmission for one or more of the following reasons: Recurrent pancreatitis; Cholecystitis; Cholangitis; Obstructive choledocholithiasis needing endoscopic retrograde cholangiopancreatography; Gallstone colic. - Complications of LC: Bile duct injury and bleeding; Requiring the need for additional surgical endoscopic, or radiological intervention; infection; Other complications such as pneumonia, bacteremia, and new-onset organ failure. - Number and severity of recurrent episodes of pancreatitis - Quality of life (QALY) - Costs (hospital and societal) - Cost-effectiveness | — |
Countries
China, Germany, Hungary, Italy, Netherlands, Norway, Spain, Sweden
Contacts
Amsterdam UMC